Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CO CLONAZEPAM 1.0 MG

CLONAZEPAM : 1.0 MG · DIN 02270668 · COBALT PHARMACEUTICALS COMPANY

Health Canada status: CANCELLED POST MARKET

What is CO CLONAZEPAM?

CO CLONAZEPAM 1.0 MG contains CLONAZEPAM : 1.0 MG. It is listed in the Health Canada Drug Product Database under DIN 02270668, held by COBALT PHARMACEUTICALS COMPANY, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 18-May-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is CO CLONAZEPAM used for?

CO CLONAZEPAM (clonazepam) is used alone or as an adjunct in the management of myoclonic and akinetic seizures and petit mal variant (Lennox-Gastaut syndrome). Co Clonazepam may also be used in the management of absence (petit mal) seizures in patients who have not responded to succinimides.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02270668
Brand nameCO CLONAZEPAM
Generic / active ingredientCLONAZEPAM : 1.0 MG
ManufacturerCOBALT PHARMACEUTICALS COMPANY
Strength1.0 MG
Dosage formTABLET
Route of administrationORAL
ScheduleTARGETED SUBSTANCES (CDSA IV)
ATC codeN03AE01 CLONAZEPAM
AHFS class28:12.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date18-May-2018
Original market date2006-02-01 00:00:00

How is it stored and handled?

Store in air-tight, light-resistant containers at controlled room temperature (15-30 °C).

How is it supplied?

Bottles of 100 and 500.

What can be used instead?

Other Canadian products sharing ATC code N03AE01 CLONAZEPAM. 8 of 55 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-CLONAZEPAM0.5 MGTABLETAPOTEX INCMARKETEDDIN 02177889
APO-CLONAZEPAM2 MGTABLETAPOTEX INCMARKETEDDIN 02177897
PMS-CLONAZEPAM0.25 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02179660
PMS-CLONAZEPAM1 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02048728
PMS-CLONAZEPAM2 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02048736
PMS-CLONAZEPAM-R0.5 MGTABLETPHARMASCIENCE INCMARKETEDDIN 02207818
RIVOTRIL0.5 MGTABLETCHEPLAPHARM ARZNEIMITTEL GMBHMARKETEDDIN 00382825
RIVOTRIL2 MGTABLETCHEPLAPHARM ARZNEIMITTEL GMBHMARKETEDDIN 00382841
ACCEL-CLONAZEPAM0.5 MGTABLETACCEL PHARMA INCCANCELLED PRE MARKETDIN 02365243
ACCEL-CLONAZEPAM1.0 MGTABLETACCEL PHARMA INCCANCELLED PRE MARKETDIN 02365251

Who else supplies CLONAZEPAM worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. CLONAZEPAM appears in 1436 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for CO CLONAZEPAM

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for CO CLONAZEPAM

Health Canada Drug Product Database (DPD), DIN 02270668. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.